I started my career as a Wall Street Research Analyst at Prudential Securities (Oil and Gas), then migrated to technology, initially Defense and Aerospace. I later formed Morningsight Capital together with Stanley Gewirtz, a physicist. Morningsight raised about $150 million for private companies, including BetaGene, Niton (handheld x-ray

fluoroscopy), Enigma Information Systems (B’nai Brak), and Sustainable Forest Systems.

I co-founded BetaGene, which developed genetically-engineered cells that display glucose-mediated insulin secretion. We sourced and formed a $40 million partnership with W.L. Gore to create an implantable device. Ultimately, this effort was defeated by a clever biological phenomenon.

Fast forward to my current endeavor: Image Navigation manufactures IGI, a surgical navigation and robotic system / GPS for dental implantology. Denx, the predecessor company to Image Navigation, had raised $24 million and, in 2006, was owned by Bex, a publicly traded Australian company. By paying off Bex's debt under an insolvency

proceeding, I became the owner of Image Navigation in 2008. At that time, DenX was essentially a company in a shipping container and Dental CT scanners—the enabling technology—were priced at $175,000, which was prohibitive for end users.

Today, dental CT scanners cost an average of $45,000 and are the standard of care for dental implantology. We are IGI version 2.0 to the European market now, under MDR, and are on plan to achieve FDA-approval in July 2026.